Testosterone undecanoate
From Infogalactic: the planetary knowledge core
(Redirected from Andriol)
File:Testosterone undecanoate.png | |
Systematic (IUPAC) name | |
---|---|
(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl undecanoate
|
|
Clinical data | |
Pregnancy category |
|
Legal status | |
Routes of administration |
oral,I.V |
Pharmacokinetic data | |
Bioavailability | 7% |
Metabolism | Liver, Testis and Prostate |
Biological half-life | 1-12 days |
Excretion | Urine |
Identifiers | |
CAS Number | 5949-44-0 |
ATC code | G03BA03 (WHO) |
PubChem | CID: 65157 |
DrugBank | DB00624 |
ChemSpider | 23089522 |
KEGG | D06087 |
Chemical data | |
Formula | C30H48O3 |
Molecular mass | 456.70032 |
|
|
(what is this?) (verify) |
Testosterone undecanoate or testosterone undecylate is an ester of testosterone. This hormone is used in androgen replacement therapy primarily for the treatment of male hypogonadism, and is currently under research for use as a male contraceptive. It is sold and distributed under the brand names Aveed, Andriol, Undestor, Nebido, Pantestone, Restandol, Cernos Depot, Nebido-R and Reandron 1000.[1]
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
External links
- testosterone undecanoate at the US National Library of Medicine Medical Subject Headings (MeSH)
<templatestyles src="Asbox/styles.css"></templatestyles>